Pharmafile

Pharmafile is a UK based portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, and pharma service company listings.


NICE recommends thyroid cancer drug trio for NHS use

NICE has announced its decision to recommend that three separate treatments for thyroid cancer should be made available for use of the NHS: Ipsen’s Cometriq (cabozantinib), Bayer’s Nexavar (sorafenib), and Eisai’s Lenvima (lenvatinib). The former two were previously only available via the Cancer Drugs Fund (CDF), and the latter sees […]


Lilly dumps Hanmi’s rheumatoid arthritis med

Eli Lilly and Hanmi signed an exclusive licensing and collaboration agreement to develop the Bruton’s tyrosine kinase (BTK) inhibitor, HM71224, for the treatment of various autoimmune and other diseases in 2015. The deal was worth a potential $690 million in total but that hasn’t stopped Lilly showing every sign of […]


Ovarian cancer risk may be inherited from the father, research indicates

Image Credit: Zappys Technology Solutions, https://www.flickr.com/photos/102642344@N02/10136583214 Researchers at the Roswell Park Comprehensive Cancer Centre in New York have published findings indicating that ovarian cancer risk may be inherited through a gene on the X chromosome of the patient’s father, independently of other genes which have already been linked to the […]


Celltrion's Herceptin biosimilar seals EU approval

Herzuma, Celltrion’s biosimilar version of Roche/Genentech’s blockbuster immunotherapy Herceptin, has been awarded approval from the European Commission, the company has revealed. The drug has been authorised in all of its reference product’s approved indications, which includes early breast cancer, metastatic breast cancer, or metastatic gastric cancer in patients whose tumours […]